Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06093724
Recruiting Not applicable

Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)

NCT06093724 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Limoges
Phase
Not applicable
Started
2023-09-08
Last updated
2025-07-22

Condition(s) studied

Transgenderism

Investigational drug(s) / intervention(s)

Static and dynamic perineo-pelvic MRI

Static and dynamic perineo-pelvic MRI: Static and dynamic perineo-pelvic MRI before surgery, and at 6 and 24 months after surgery.

Study summary

The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient over 18 years old * Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty * Patient affiliated or benefitting from a social security system * Patient free, informed, written and signed consent Exclusion Criteria: * Patient admitted for vulvoplasty surgery * Patient admitted for second vaginoplasty surgical gesture * Contraindication of realizing an MRI

Primary outcome measure(s)

  • Measurement comparison of the rectal bulge's size and classification — 6 months and 24 months
    Comparison and classification by pre-operative and post-operative MRI

Trial sites (1)

FacilityCityRegionStatus
University Hospital, Limoges Limoges Limoges Recruiting

More University Hospital, Limoges trials in France

Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression Recruiting
Effects of the COTID (Community Occupational Therapist in Dementia) Program and Usual Occupational Therapy Care on Recurrence of Falls at 12 Months in Elderly People With Neurocognitive Disorders Who Had Been Hospitalized for Falls, After Their Return Home Recruiting
INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS Starting soon
DELTA DESCRIBE: the French Collaborative Project Recruiting
Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06093724 on ClinicalTrials.gov ↗ ← All trials in France